Novartis AG

Swiss Stock Exchange:NOVN.SW

Location

Market Cap

USD 242.43 B

Share Price

USD 116.76

Avg Daily Volume

3,462,718

Change (1 day)

-0.49%

Change (1 year)

6.28%

Change (YTD)

19.04%

Novartis AG EBITDA Margin for the year ending December 31, 2024: 40.05%

Novartis AG EBITDA Margin is 40.05% for the year ending December 31, 2024, a 2.37% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Novartis AG EBITDA Margin for the year ending December 31, 2023 was 39.12%, a 38.11% change year over year.
  • Novartis AG EBITDA Margin for the year ending December 31, 2022 was 28.33%, a -51.55% change year over year.
  • Novartis AG EBITDA Margin for the year ending December 31, 2021 was 58.46%, a 69.50% change year over year.
  • Novartis AG EBITDA Margin for the year ending December 31, 2020 was 34.49%, a 7.52% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin